Richardson P D, Withrington P G
Br J Pharmacol. 1977 Feb;59(2):293-301. doi: 10.1111/j.1476-5381.1977.tb07492.x.
1 The hepatic portal vein of the anesthetized dog was cannulated and perfused with blood derived from the cannulated superior mesenteric vein. 2 The portal vein was perfused at constant flow, the hepatic portal venous pressure being monitored continuously together with the inferior vena caval pressure. From these measurements, the hepatic portal venous vascular resistance was calculated. 3 Noradrenaline and adrenaline were injected intraportally in graded doses which caused dose-dependent increases in the hepatic portal vascular resistance. At all doses, adrenaline was significantly (P less than 0.05) more potent than noradrenaline. 4 Intraportal injections of vasopressin caused reductions in calculated hepatic portal venous vascular resistance in most experiments; three effects were dose-dependent. 5 No tachyphylaxis to the effects of noradrenaline, adrenaline or vasopressin was observed. 6 Intraportal injections of angiotensin caused dose-dependent increases in calculated hepatic portal vascular resistance up to 5 mug; therafter larger doses caused smaller increases in portal resistance. 7. Repeated intraportal injections of angiotensin revealed the existence of tachyphylaxis in the hapatic portal vascular bed. 8 Intraportal infusions of anagiotensin caused rises in calculated hepatic portal vascular resistance from which there was almost complete 'escape' despite the continued infusions. Infusions of noradrenaline which caused similar rises in calculated portal vascular resistance did not exhibit equivalent degrees of 'escape'. 9 The development of tachyphylaxisx explains the fact that doses of 10 and 20 mug of angiotensin injected after 5 mug doses produced smaller effects. If a much longer time interval was allowed between injections (30 min), the dose-response curve to angiotensin had a sigmoid shape. 10 These findings are discussed with respect to their possible importance in the functional status of the hepatic portal vascular bed in this species.
将麻醉犬的肝门静脉插管,并用来自插管的肠系膜上静脉的血液进行灌注。
以恒定流量灌注门静脉,同时连续监测肝门静脉压力和下腔静脉压力。根据这些测量结果,计算肝门静脉血管阻力。
去甲肾上腺素和肾上腺素经门静脉以分级剂量注射,导致肝门静脉血管阻力呈剂量依赖性增加。在所有剂量下,肾上腺素的效力均显著高于去甲肾上腺素(P小于0.05)。
在大多数实验中,经门静脉注射血管加压素可使计算出的肝门静脉血管阻力降低;有三种效应呈剂量依赖性。
未观察到对去甲肾上腺素、肾上腺素或血管加压素作用的快速耐受性。
经门静脉注射血管紧张素可使计算出的肝门静脉血管阻力呈剂量依赖性增加,直至5微克;此后,更大剂量导致门静脉阻力增加较小。
重复经门静脉注射血管紧张素显示肝门静脉血管床存在快速耐受性。
经门静脉输注血管紧张素可使计算出的肝门静脉血管阻力升高,尽管持续输注,但几乎完全“逃逸”。输注去甲肾上腺素导致计算出的门静脉血管阻力有类似升高,但未表现出同等程度的“逃逸”。
快速耐受性的发展解释了在5微克剂量后注射10微克和20微克血管紧张素产生较小效应的事实。如果在注射之间允许更长的时间间隔(30分钟),血管紧张素的剂量-反应曲线呈S形。
讨论了这些发现对于该物种肝门静脉血管床功能状态可能的重要性。